194 related articles for article (PubMed ID: 22822927)
21. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children.
Strunk RC; Szefler SJ; Phillips BR; Zeiger RS; Chinchilli VM; Larsen G; Hodgdon K; Morgan W; Sorkness CA; Lemanske RF;
J Allergy Clin Immunol; 2003 Nov; 112(5):883-92. PubMed ID: 14610474
[TBL] [Abstract][Full Text] [Related]
22. Quality of life and inflammatory markers in mild asthma.
Ehrs PO; Sundblad BM; Larsson K
Chest; 2006 Mar; 129(3):624-31. PubMed ID: 16537860
[TBL] [Abstract][Full Text] [Related]
23. Airway responsiveness to hypertonic saline: dose-response slope or PD15?
de Meer G; Marks GB; de Jongste JC; Brunekreef B
Eur Respir J; 2005 Jan; 25(1):153-8. PubMed ID: 15640337
[TBL] [Abstract][Full Text] [Related]
24. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline.
Brannan JD; Anderson SD; Perry CP; Freed-Martens R; Lassig AR; Charlton B;
Respir Res; 2005 Dec; 6(1):144. PubMed ID: 16336673
[TBL] [Abstract][Full Text] [Related]
25. Relationship of the asthma control test with pulmonary function and exhaled nitric oxide.
Shirai T; Furuhashi K; Suda T; Chida K
Ann Allergy Asthma Immunol; 2008 Dec; 101(6):608-13. PubMed ID: 19119704
[TBL] [Abstract][Full Text] [Related]
26. Airway responsiveness to hyperosmolar saline challenge in cystic fibrosis: a pilot study.
Rodwell LT; Anderson SD
Pediatr Pulmonol; 1996 May; 21(5):282-9. PubMed ID: 8726153
[TBL] [Abstract][Full Text] [Related]
27. Association between asthma control and bronchial hyperresponsiveness and airways inflammation: a cross-sectional study in daily practice.
Quaedvlieg V; Sele J; Henket M; Louis R
Clin Exp Allergy; 2009 Dec; 39(12):1822-9. PubMed ID: 19817755
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of exhaled nitric oxide measurements in the emergency department for patients with acute asthma.
Baptist AP; Sengupta R; Pranathiageswaran S; Wang Y; Ager J
Ann Allergy Asthma Immunol; 2008 May; 100(5):415-9. PubMed ID: 18517071
[TBL] [Abstract][Full Text] [Related]
29. [Study of bronchial reactivity using dry, cold air and eucapnic hyperventilation].
Mojsoski N; Pavicić F
Plucne Bolesti; 1990; 42(1-2):38-42. PubMed ID: 2120718
[TBL] [Abstract][Full Text] [Related]
30. Peak expiratory flow variability adjusted by forced expiratory volume in one second is a good index for airway responsiveness in asthmatics.
Matsunaga K; Kanda M; Hayata A; Yanagisawa S; Ichikawa T; Akamatsu K; Koarai A; Hirano T; Sugiura H; Minakata Y; Ichinose M
Intern Med; 2008; 47(12):1107-12. PubMed ID: 18552467
[TBL] [Abstract][Full Text] [Related]
31. Hypertonic saline challenge in an epidemiologic survey of asthma in children.
Riedler J; Reade T; Dalton M; Holst D; Robertson C
Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1632-9. PubMed ID: 7952626
[TBL] [Abstract][Full Text] [Related]
32. [Sensitivity of sputum eosinophil cationic protein level for monitoring asthmatic patients with normal peak expiratory flow].
Nakazawa T; Kagami M; Matumura R; Kawashima T; Matuzuwa Y; Takada M
Arerugi; 1999 Oct; 48(10):1153-60. PubMed ID: 10554401
[TBL] [Abstract][Full Text] [Related]
33. Cough frequency in children with stable asthma: correlation with lung function, exhaled nitric oxide, and sputum eosinophil count.
Li AM; Lex C; Zacharasiewicz A; Wong E; Erin E; Hansel T; Wilson NM; Bush A
Thorax; 2003 Nov; 58(11):974-8. PubMed ID: 14586052
[TBL] [Abstract][Full Text] [Related]
34. Comparison of eNO and histamine hyperresponsiveness in diagnosing asthma in new referrals.
Munnik P; van der Lee I; Fijn J; van Eijsden LJ; Lammers JW; Zanen P
Respir Med; 2010 Jun; 104(6):801-7. PubMed ID: 20036525
[TBL] [Abstract][Full Text] [Related]
35. [Cold provocation test. A method for diagnosis of bronchial asthma].
Bach-Gansmo E; Skjønsberg O; Boye NP
Tidsskr Nor Laegeforen; 1992 Feb; 112(5):628-9. PubMed ID: 1557728
[TBL] [Abstract][Full Text] [Related]
36. [Peculiarities of cell reception in bronchial asthma patients with bronchial hyperreactivity to hyperosmolar provocation].
Minaev VN; Sinitsina TM; Adamova IV; Nesterovich II
Ter Arkh; 2000; 72(1):63-5. PubMed ID: 10687212
[TBL] [Abstract][Full Text] [Related]
37. Assessment of inhaled corticosteroid treatment response in asthma using hypertonic histamine challenge-induced cough.
Purokivi M; Koskela H; Koistinen T; Peuhkurinen K; Kontra KM
Clin Respir J; 2010 Apr; 4(2):67-73. PubMed ID: 20565479
[TBL] [Abstract][Full Text] [Related]
38. Expired nitric oxide after bronchoprovocation and repeated spirometry in patients with asthma.
Deykin A; Halpern O; Massaro AF; Drazen JM; Israel E
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):769-75. PubMed ID: 9517589
[TBL] [Abstract][Full Text] [Related]
39. Diurnal variation of peak expiratory flow in children with cough variant asthma.
Tokuyama K; Shigeta M; Maeda S; Takei K; Hoshino M; Morikawa A
J Asthma; 1998; 35(2):225-9. PubMed ID: 9576149
[TBL] [Abstract][Full Text] [Related]
40. The relative contributions of histamine and prostanoids to bronchoconstriction provoked by isocapnic hyperventilation in asthma.
Finnerty JP; Harvey A; Holgate ST
Eur Respir J; 1992 Mar; 5(3):323-30. PubMed ID: 1572446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
